Documenting Update Cadence for an FDA
How to document update cadence for an FDA §524B submission: the regular cycle and the out-of-cycle expedited path reviewers expect under §524B(b)(2)(B).
Read articleEvery article in our archive tagged Premarket.
Showing 12 of 16 articles tagged Premarket · Page 1 of 2
How to document update cadence for an FDA §524B submission: the regular cycle and the out-of-cycle expedited path reviewers expect under §524B(b)(2)(B).
Read article
FDA Section 524B applies to any new premarket submission for a cyber device, including legacy platforms.
Read article
What medical device cybersecurity actually costs in 2026: four cost drivers, fixed-fee vs hourly pricing, and premarket vs postmarket budget lines.
Read article
A subsection-by-subsection walkthrough of FDA Section 524B for cyber medical devices: what §524B(a), (b)(1), (b)(2), (b)(3), (b)(4), and (c) require.
Read article
Class I, II, III doesn't decide your FDA cybersecurity burden. Section 524B's cyber-device test and whether you file a premarket submission do.
Read article
What the FDA's Feb 2026 premarket guidance actually requires for medical device penetration testing - what's inside a real pen test, what's separate.
Read article
When a cybersecurity change to a cleared medical device stays as a letter to file in the DHF, and when it forces a new 510(k).
Read article
When the FDA accepts a Special 510(k) for cybersecurity changes - BLE, firmware signing, Secure Boot, SBOM swaps - and when it pushes you to Traditional.
Read article
The concrete SBOM elements FDA reviewers verify at RTA screening: format, identifiers, vulnerability disposition, and update process, based on 250+ reviews.
Read article
Learn how to organize FDA medical device cybersecurity requirements into 18 key deliverables, from threat modeling and SBOMs to testing and labeling.
Read article
Cybersecurity is no longer optional - it’s critical to patient safety and regulatory success.
Read article
Navigating the FDA clearance process for medical devices involves more than technical documentation and testing - it involves significant regulatory.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.